drugset / Trial / NCT06569212
Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS)
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine the effect of early metoprolol administration after non-traumatic subarachnoid hemorrhage (SAH).
Timeline
- Start
- 2024-09-23
- Primary completion
- 2026-09
- Completion
- 2029-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metoprolol | Other / unclassified | 5 mg | Oral |
| Subject | Metoprolol | Other / unclassified | 25 mg | Oral |